Filing Details
- Accession Number:
- 0001209191-20-002038
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-01-06 17:28:55
- Reporting Period:
- 2020-01-02
- Accepted Time:
- 2020-01-06 17:28:55
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1610618 | Cidara Therapeutics Inc. | CDTX | Biological Products, (No Disgnostic Substances) (2836) | 461537286 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1760712 | Jessica Oien | C/O Cidara Therapeutics, Inc. 6310 Nancy Ridge Dr, Ste 101 San Diego CA 92121 | General Counsel & Secretary | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-01-02 | 834 | $3.86 | 6,965 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs on 12/31/19. These sales are mandated by the Reporting Person's election to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.